Correction: PAX6 promotes neuroendocrine phenotypes of prostate cancer via enhancing MET/STAT5Amediated chromatin accessibility

• Nan Jing,
• Xinxing Du,
• Yu Liang,
• ZhenKeke Tao,
• Shijia Bao,
• Huixiang Xiao,
• Baijun Dong,
• Wei-Qiang Gao,
• Yu-Xiang Fang

Affiliations

Nan Jing

State Key Laboratory of Systems Medicine for Cancer, Renji-Med-X Stem Cell Research Center, Ren Ji Hospital, School of Medicine, School of Biomedical Engineering, Shanghai Jiao Tong University

Xinxing Du

Department of Urology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University

Yu Liang

State Key Laboratory of Molecular Developmental Biology, Institute of Genetics and Developmental Biology, Chinese Academy of Sciences

ZhenKeke Tao

State Key Laboratory of Systems Medicine for Cancer, Renji-Med-X Stem Cell Research Center, Ren Ji Hospital, School of Medicine, School of Biomedical Engineering, Shanghai Jiao Tong University

Shijia Bao

State Key Laboratory of Systems Medicine for Cancer, Renji-Med-X Stem Cell Research Center, Ren Ji Hospital, School of Medicine, School of Biomedical Engineering, Shanghai Jiao Tong University

Huixiang Xiao

State Key Laboratory of Systems Medicine for Cancer, Renji-Med-X Stem Cell Research Center, Ren Ji Hospital, School of Medicine, School of Biomedical Engineering, Shanghai Jiao Tong University

Baijun Dong

Department of Urology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University

Wei-Qiang Gao

State Key Laboratory of Systems Medicine for Cancer, Renji-Med-X Stem Cell Research Center, Ren Ji Hospital, School of Medicine, School of Biomedical Engineering, Shanghai Jiao Tong University

Yu-Xiang Fang

State Key Laboratory of Systems Medicine for Cancer, Renji-Med-X Stem Cell Research Center, Ren Ji Hospital, School of Medicine, School of Biomedical Engineering, Shanghai Jiao Tong University